logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

RITAMIX (01936) to resume trading on September 28

date
09:01 28/09/2026
avatar
GMT Eight
RITAMIX (01936) announced that trading in the company's shares will resume at 9:00 a.m. on September 28, 2026.
RITAMIX (01936) announced that trading in the company's shares will resume at 9:00 a.m. on September 28, 2026.
Related Articles
HK Stock Market Move | Gold stocks fall across the board; rising U.S. Treasury yields weigh on precious metals valuations; Fed officials release hawkish signals.
China Stock
Sinolink: TV panel makers issue price increase letters; National Day holiday maintenance adjusts supply and demand.
HK Stock Market Move | LEPU BIO (02157) rises over 4% as CMG901 clinical study results selected for LBA and to be presented at a Presidential Symposium
HK Stock Market Move | Gold stocks fall across the board; rising U.S. Treasury yields weigh on precious metals valuations; Fed officials release hawkish signals.
Sinolink: TV panel makers issue price increase letters; National Day holiday maintenance adjusts supply and demand.
China Stock
HK Stock Market Move | LEPU BIO (02157) rises over 4% as CMG901 clinical study results selected for LBA and to be presented at a Presidential Symposium
RECOMMEND
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
icon
25/09/2026
From IT Services to Enterprise AI: What ATGL Must Prove Next
From IT Services to Enterprise AI: What ATGL Must Prove Next
icon
24/09/2026
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
icon
22/09/2026
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.